201 related articles for article (PubMed ID: 36272020)
21. Differential efficacy of human mesenchymal stem cells based on source of origin.
Collins E; Gu F; Qi M; Molano I; Ruiz P; Sun L; Gilkeson GS
J Immunol; 2014 Nov; 193(9):4381-90. PubMed ID: 25274529
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.
Sun L; Akiyama K; Zhang H; Yamaza T; Hou Y; Zhao S; Xu T; Le A; Shi S
Stem Cells; 2009 Jun; 27(6):1421-32. PubMed ID: 19489103
[TBL] [Abstract][Full Text] [Related]
23. Cross Talk between Mesenchymal Stem/Stromal Cells and Innate Immunocytes Concerning Lupus Disease.
Mahmoudi M; Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S
Stem Cell Rev Rep; 2022 Dec; 18(8):2781-2796. PubMed ID: 35876958
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cell therapy induces FLT3L and CD1c
Yuan X; Qin X; Wang D; Zhang Z; Tang X; Gao X; Chen W; Sun L
Nat Commun; 2019 Jun; 10(1):2498. PubMed ID: 31175312
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.
Yang C; Sun J; Tian Y; Li H; Zhang L; Yang J; Wang J; Zhang J; Yan S; Xu D
Front Immunol; 2021; 12():714832. PubMed ID: 34603289
[TBL] [Abstract][Full Text] [Related]
26. Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus.
Cao Z; Wang D; Jing L; Wen X; Xia N; Ma W; Zhang X; Jin Z; Shen W; Yao G; Chen W; Tang X; Geng L; Li H; Li X; Ding S; Liang J; Feng X; Zhang H; Liu S; Li W; Sun L
Stem Cells Transl Med; 2023 Jul; 12(7):431-443. PubMed ID: 37279956
[TBL] [Abstract][Full Text] [Related]
27. A New Target of Dental Pulp-Derived Stem Cell-Based Therapy on Recipient Bone Marrow Niche in Systemic Lupus Erythematosus.
Sonoda S; Yamaza T
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408840
[TBL] [Abstract][Full Text] [Related]
28. Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.
Xu J; Chen J; Li W; Lian W; Huang J; Lai B; Li L; Huang Z
J Am Soc Nephrol; 2020 Jan; 31(1):54-65. PubMed ID: 31604808
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice.
Yang X; Yang J; Li X; Ma W; Zou H
Lupus; 2018 Jan; 27(1):49-59. PubMed ID: 28537524
[TBL] [Abstract][Full Text] [Related]
30. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients.
Carrion F; Nova E; Ruiz C; Diaz F; Inostroza C; Rojo D; Mönckeberg G; Figueroa FE
Lupus; 2010 Mar; 19(3):317-22. PubMed ID: 19919974
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.
Zaripova LN; Midgley A; Christmas SE; Beresford MW; Pain C; Baildam EM; Oldershaw RA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003230
[TBL] [Abstract][Full Text] [Related]
32. Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus.
Feng X; Che N; Liu Y; Chen H; Wang D; Li X; Chen W; Ma X; Hua B; Gao X; Tsao BP; Sun L
Arthritis Rheumatol; 2014 Dec; 66(12):3413-23. PubMed ID: 25219468
[TBL] [Abstract][Full Text] [Related]
33. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
Zhang H; Zeng X; Sun L
Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
[TBL] [Abstract][Full Text] [Related]
34. Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus.
Zheng B; Zhang P; Yuan L; Chhetri RK; Guo Y; Deng D
Lupus; 2020 Feb; 29(2):126-135. PubMed ID: 31870216
[TBL] [Abstract][Full Text] [Related]
35. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.
Liu F; Chen H; Chen T; Lau CS; Yu FX; Chen K; Chen HP; Pan RS; Chan GC; Zhang XY; Nie YJ
Lupus; 2020 Jul; 29(8):872-883. PubMed ID: 32580680
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
38. Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.
Gao L; Bird AK; Meednu N; Dauenhauer K; Liesveld J; Anolik J; Looney RJ
Arthritis Rheumatol; 2017 Aug; 69(8):1623-1635. PubMed ID: 28471483
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
Liu S; Guo YL; Yang JY; Wang W; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
[TBL] [Abstract][Full Text] [Related]
40. Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus.
Park MJ; Kwok SK; Lee SH; Kim EK; Park SH; Cho ML
Cell Transplant; 2015; 24(11):2367-77. PubMed ID: 25506685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
